Search Results 321-330 of 8982 for Conduction

1. Study to Evaluate the Safety, Tolerability and Preliminary Antitumor Activity of INCB059872 in Patients with Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

   For participants with an intraventricular conduction delay (QRS interval ≥ 120 ms), the JTc interval may be used in place of the QTc with sponsor approval.

2. A Study Evaluating Pembrolizumab and Epacadostat in Treating Participants With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma - Mayo Clinic

   For subjects with an intraventricular conduction delay (QRS interval > 120 msec), the JTc interval may be used in place of the QTc with sponsor approval.

3. Discovery's Edge: Beat still my beating heart - Mayo Clinic News Network

   Langendorff systems have been used to test the effects of drugs on the heart, electrical conduction, the effect of genetic mutations, and myriad of other ...

4. Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma - Mayo Clinic

   Active conduction system abnormalities; NOTE: prior to study entry, any electrocardiogram (ECG) abnormality at screening must be documented by the ...

5. Physical Medicine and Rehabilitation - Tests and procedures - Mayo Clinic

   Nerve conduction studies; Nerve flossing; Nerve hydrodissection; Neural tensioning; Neurogenic bladder and bowel management · Neurological examinations ...

6. Ablation therapy - Doctors & Departments - Mayo Clinic

   ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

7. A Study to Evaluate the Safety and Effectiveness of Capivasertib + Fulvestrant Versus Placebo + Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Breast Cancer - Mayo Clinic

   Any clinically important abnormalities in rhythm, conduction or morphology of resting ECG (e.g., complete left bundle branch block, third degree heart block); ...

8. MC200404, Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Late-stage Metastatic Colorectal Cancer - Mayo Clinic

   ... conduction system abnormalities;; Administration of a live, attenuated vaccine ≤ 4 weeks prior to registration or anticipation of a live attenuated vaccine ...

9. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

   ... conduction abnormalities. Patients with history of cardiac disease, such as coronary disease, arrhythmia or congestive heart failure that are on appropriate ...

10. Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

    ... conduction system abnormalities; NOTE: Prior to study entry, any electrocardiogram (ECG) abnormality at screening has to be documented by the investigator ...